Texas Biotech (TXB) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill Wexler who wrote (579)	2/18/1998 10:11:00 PM
From: Brander	Read Replies (1) of 834

TXB is one of the highest rated speculative biotechs. It is ranked 4/118 in its sector by Zacks. It also is rated a strong buy by Zacks. All research reports out rate TXB as a speculative strong buy. The share dilution is not bad at all compared to other developing biotechs. The earnings report was also not bad, and revealed improvement in some areas. It was superior to other biotechs in a similar phase of development. They have one drug that could be approved very soon by the FDA. If so, financing will no longer be an issue. quote.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next